carmel semaglutide A photo illustration of an Ozempic pen seen sitting on a table in Carmel, IN on Jan. 26, 2023. The diabetes drug Ozempic has seen supply chain issues due to off label Ozempic Will Give Way to

Semaglutide is a selective glucagon-like peptide-1 (GLP-1) receptor agonist used in laboratory research to investigate incretin receptor signalling, glucose homeostasis mechanisms, and metabolic pathway regulation in experimental models

Its effective, but your body is smart and adapts over time

Its not growth hormone itself, but something that stimulates your body to produce growth hormone naturally from the pituitary gland, which sits just beneath your brain

Starting above 0.25 mg is technically off-label but is commonly used in specialist obesity and endocrinology practice for patients transitioning from another GLP-1 medication

My skin looks great even days later

Participants who had lost weight on semaglutide were switched to placebo